James Blevins

Research Associate Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

James Blevins is a Research Associate Professor at the University of Washington, USA. His research focuses on the metabolic effects of oxytocin and its implications in obesity treatment, as evident from his recent publications. Blevins has explored the role of chimeric peptides and sympathetic innervation in body weight regulation and energy expenditure in diet-induced obese models.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Kevin O'Brien

Professor

University of Washington

UNITED STATES

View details

Emily Noble

Assistant Professor

University of Georgia

UNITED STATES

View details

Robert P. Doyle

Syracuse University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Blevins

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

The Chimeric Peptide (GEP44) Reduces Body Weight and Both Energy Intake and Energy Expenditure in Diet-Induced Obese Rats

Editorial: Oxytocin and metabolic dysregulation: from pathophysiology to pharmacotherapy.

Effects of systemic oxytocin and beta‐3 receptor agonist (CL 316243) treatment on body weight and adiposity in male diet‐induced obese rats

Sympathetic Innervation of Interscapular Brown Adipose Tissue Is Not a Predominant Mediator of Oxytocin-Induced Brown Adipose Tissue Thermogenesis in Female High Fat Diet-Fed Rats

Sympathetic innervation of interscapular brown adipose tissue is not a predominant mediator of Oxytocin (OT)-elicited reductions of body weight gain and adiposity in male diet-induced obese rats

Sympathetic innervation of interscapular brown adipose tissue is not a predominant mediator of oxytocin-elicited reductions of body weight and adiposity in male diet-induced obese mice

The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner

Oxytocin as a potential pharmacological tool to combat obesity

Novel Long-Acting Oxytocin Analog with Increased Efficacy in Reducing Food Intake and Body Weight

Hindbrain Administration of Oxytocin Reduces Food Intake, Weight Gain and Activates Catecholamine Neurons in the Hindbrain Nucleus of the Solitary Tract in Rats

Robust Reductions of Body Weight and Food Intake by an Oxytocin Analog in Rats.

Effects of Combined Oxytocin and Beta-3 Receptor Agonist (CL 316243) Treatment on Body Weight and Adiposity in Male Diet-Induced Obese Rats.

Chronic hindbrain administration of oxytocin elicits weight loss in male diet-induced obese mice

Oxytocin as an Anti-obesity Treatment.

The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis

Collaborators (3)

Kevin O'Brien

Emily Noble

Robert P. Doyle

Make your next move.